Clinical Trials
10 trialsNCT07493304 2026-05-29
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT04618913 2026-05-26
VICTORIE
Pfizer
Active not recruiting
NCT06886516 2026-04-15
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Recruiting
NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT07005024 2026-02-05
DOAC
University of Vermont
Phase 3 Recruiting
NCT05683808 2026-01-30
VTE-POG
University of Vermont Medical Center
Phase 2 Recruiting
NCT07270263 2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA Recruiting
NCT07189897 2025-10-08
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
State University of New York - Upstate Medical University
Phase 4 Recruiting
NCT02066454 2025-08-13
MYELAXAT
University Hospital, Grenoble
Phase 3 Completed
NCT03045406 2025-06-24
CARAVAGGIO
Fadoi Foundation, Italy
Phase 3 Completed